| abstract |
The present invention further provides pharmaceutical compositions, dosage ranges, and treatment regimens for administering AMG 900 to treat cancer. The present invention relates to a method of using AMG900, a small molecule pan-Aurora kinase inhibitor, for the treatment of cancer, including solid tumors, tumors derived from blood, and the like. Specifically, it was unexpectedly discovered that AMG 900 slowed the growth and / or progression of various solid tumor cancers in a patient when administered to a cancer patient at a predetermined dosage range over a predetermined treatment plan. It was done. [Selection] Figure 1 |